C
Veracyte, Inc. VCYT
$30.96 -$0.14-0.45%
Recommendation
Hold
Prev Close
$31.10
Volume
810,320
Avg Vol (90D)
876,473
Market Cap
$2.42B
Dividend & Yield
--
52-Week Range
$18.61 - $47.32
P/E (TTM)
104.93
EPS (TTM)
$0.2964
My Lists My Alerts
Rating
Reward
C
Fair
Risk
D
Weak
Rating Factors
Growth Index
Good
Efficiency Index
Fair
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Veracyte (VCYT, $31.1) Aroon Indicator entered a Downtrend on March 11, 2025.
3/12/2025 - Tickeron - Stocks
Veracyte (VCYT, $30.38) Aroon Indicator entered a Downtrend on March 10, 2025.
3/11/2025 - Tickeron - Stocks
Veracyte (VCYT, $30.38) Aroon Indicator entered a Downtrend on March 10, 2025.
3/11/2025 - Tickeron - Stocks
M&T Bank Corp Buys 10,121 Shares of Veracyte, Inc. (NASDAQ:VCYT)
3/9/2025 - MarketBeat
Veracyte (VCYT, $32.02) Aroon Indicator entered a Downtrend on March 07, 2025.
3/8/2025 - Tickeron - Stocks
Shareholders Can Be Confident That Veracyte's (NASDAQ:VCYT) Earnings Are High Quality
3/8/2025 - Simply Wall St
29,779 Shares in Veracyte, Inc. (NASDAQ:VCYT) Purchased by Proficio Capital Partners LLC
3/8/2025 - MarketBeat
Veracyte (VCYT, $32.51) Aroon Indicator entered a Downtrend on March 06, 2025.
3/7/2025 - Tickeron - Technical Analysis
Veracyte (VCYT, $32.51) Aroon Indicator entered a Downtrend on March 06, 2025.
3/7/2025 - Tickeron - Stocks
Vestmark Advisory Solutions Inc. Increases Holdings in Veracyte, Inc. (NASDAQ:VCYT)
3/7/2025 - MarketBeat
Insider Sell: Phillip Febbo Sells Shares of Veracyte Inc (VCYT)
3/7/2025 - GuruFocus
Veracyte (VCYT, $32.96) Aroon Indicator entered a Downtrend on March 05, 2025.
3/6/2025 - Tickeron - Stocks
Veracyte (VCYT, $32.96) Aroon Indicator entered a Downtrend on March 05, 2025.
3/6/2025 - Tickeron - Stocks
Analysts Predict 21% Upside For THNQ
3/6/2025 - ETF Channel
Veracyte (VCYT, $32.96) Aroon Indicator entered a Downtrend on March 05, 2025.
3/6/2025 - Tickeron - Stocks
Veracyte Inc (VCYT) Shares Down 2.49% on Mar 5
3/5/2025 - GuruFocus
Veracyte (VCYT, $34.11) Aroon Indicator entered a Downtrend on March 04, 2025.
3/5/2025 - Tickeron - Stocks
Veracyte, Inc. (NASDAQ:VCYT) Looks Inexpensive After Falling 26% But Perhaps Not Attractive Enough
3/4/2025 - Simply Wall St
Veracyte (VCYT, $33.56) Aroon Indicator entered a Downtrend on March 03, 2025.
3/4/2025 - Tickeron - Stocks
Veracyte (VCYT, $34.76) Aroon Indicator entered a Downtrend on February 28, 2025.
3/1/2025 - Tickeron - Stocks
Decoding Veracyte Inc (VCYT): A Strategic SWOT Insight
3/1/2025 - GuruFocus
Veracyte Inc (VCYT) Shares Up 3.52% on Feb 28
2/28/2025 - GuruFocus
Y Intercept Hong Kong Ltd Purchases New Position in Veracyte, Inc. (NASDAQ:VCYT)
2/28/2025 - MarketBeat
Veracyte (NASDAQ:VCYT) Rating Lowered to "Hold" at StockNews.com
2/28/2025 - MarketBeat
Phocas Financial Corp. Decreases Stake in Veracyte, Inc. (NASDAQ:VCYT)
2/27/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$445.76M
EBITDA (TTM)
$50.90M
EBIT (TTM)
$27.44M
Net Income (TTM)
$24.14M
Balance Sheet
Total Assets (Q)
$1.30B
Total Debt (Q)
$50.74M
Total Liabilities (Q)
$124.07M
Book Value Per Share (Q)
$15.12
Cash Flow
Cash from Operations (TTM)
$75.10M
Cash from Investing (TTM)
-$56.28M
Cash from Financing (TTM)
$4.90M
Net Change in Cash (TTM)
$23.30M
Filings
Filing Date
Friday, February 28, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
2.08
7-Day Total Return
-7.75%
30-Day Total Return
-29.10%
60-Day Total Return
-28.84%
90-Day Total Return
-9.95%
Year to Date Total Return
-23.44%
1-Year Total Return
38.71%
2-Year Total Return
36.51%
3-Year Total Return
41.11%
5-Year Total Return
55.81%
52-week Low
Apr 18, 2024 - $18.61
52-week High
Jan 30, 2025 - $47.32
Valuation
Market Cap
$2.42B - Mid Cap
Enterprise Value
$2.19B
Price/Sales (TTM)
5.57
Price/Book (Q)
2.06
Dividends and Shares
Shares Outstanding
79.91M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.veracyte.com
Phone Number
650 243 6300
Address
6000 Shoreline Court
South San Francisco, CA 94080
Country
United States
Year Founded
2006
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate... more
NASDAQ 03/12/2025 4:00PM Eastern Quotes delayed
Weiss Ratings